Inhibition of p97 with the First-in-Class Small Molecule CB-5083: A Novel Strategy for Acute Myeloid Leukemia Therapy
Rita Tohmé(Case Western Reserve University), Jennifer S. Carew(University of Arizona), Steve Wong, Hetty E. Carraway(Cleveland Clinic), Bartlomiej Przychodzen(Cleveland Clinic), Stevan Djakovic, Ronan Le Moigne, Yogen Saunthararajah(Cleveland Clinic), Mikkael A. Sekeres(University of Miami), Mark Rolfe(Unknown), Steffan T. Nawrocki(University of Arizona), Yingchun Han(Shenyang Agricultural University), D.T. Anderson, Anjali S. Advani(Cleveland Clinic), Han-Jie Zhou, David J. Wustrow(Rapt Therapeutics (United States)), Jaroslaw P. Maciejewski(Cleveland Clinic), Kevin R. Kelly(Keck Hospital of USC)
Cited by 0
Related Papers
Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
|Science|1995|1.8k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k